Infectious Diseases News and Research RSS Feed - Infectious Diseases News and Research

Researchers to explore how Zika virus enters human cells

Researchers to explore how Zika virus enters human cells

A group of Western Illinois University student and faculty researchers are spending the summer conducting surveillance of tick-borne diseases and mosquito-borne arboviruses in regional counties. [More]
New Bruker In-Vivo Xtreme II system accelerates preclinical infectious disease research at University of Lausanne

New Bruker In-Vivo Xtreme II system accelerates preclinical infectious disease research at University of Lausanne

Bruker’s recently introduced preclinical in vivo imaging system – In-Vivo Xtreme II™– is accelerating the preclinical research into infectious diseases being undertaken at the Institute of Microbiology at the University of Lausanne, Switzerland. Infectious diseases are the second leading cause of death worldwide. [More]
Scientists isolate antibodies capable of neutralizing dengue and Zika virus

Scientists isolate antibodies capable of neutralizing dengue and Zika virus

Scientists from the Institut Pasteur and the CNRS, in collaboration with Imperial College London and the University of Vienna, Austria, have identified antibodies that can efficiently neutralize both the dengue virus and the Zika virus. [More]
SLU to conduct human clinical trial of vaccine to protect people from Zika virus

SLU to conduct human clinical trial of vaccine to protect people from Zika virus

Saint Louis University's vaccine center has been tapped by the National Institutes of Health to conduct a human clinical trial of a vaccine to prevent the Zika virus, which can cause devastating birth defects in babies. [More]
Research shows enveloped viruses could survive on toys long enough to cause infection

Research shows enveloped viruses could survive on toys long enough to cause infection

Certain viruses, such as influenza, could survive on children's toys long enough to result in exposures, placing children at risk for getting infectious diseases, according to researchers at Georgia State University. [More]
Study to evaluate magnitude of health risks caused by Zika virus in pregnant women, infants

Study to evaluate magnitude of health risks caused by Zika virus in pregnant women, infants

The National Institutes of Health and Fundacao Oswaldo Cruz-Fiocruz, a national scientific research organization linked to the Brazilian Ministry of Health, have begun a multi-country study to evaluate the magnitude of health risks that Zika virus infection poses to pregnant women and their developing fetuses and infants. [More]
Mobile devices of healthcare workers often contaminated by viral RNA

Mobile devices of healthcare workers often contaminated by viral RNA

In clinical settings, mobile phones benefit patients by placing useful data and information at the fingertips of health professionals during interactions on the ward. [More]
Composition of microbiota plays significant role in body's ability to accept transplanted tissue

Composition of microbiota plays significant role in body's ability to accept transplanted tissue

Researchers from the University of Chicago have shown that microbiota—the bacteria, viruses and other microbes living on the skin and in the digestive system—play an important role in the body's ability to accept transplanted skin and other organs. [More]
VUMC researchers aim to decode genetic underpinnings of human immune system

VUMC researchers aim to decode genetic underpinnings of human immune system

Researchers at Vanderbilt University Medical Center this month began recruiting volunteers to participate in a clinical trial aimed at decoding the human "immunome," the genetic underpinnings of the immune system. [More]
Study emphasizes need for Ryan White HIV/AIDS Program to receive basic HIV care

Study emphasizes need for Ryan White HIV/AIDS Program to receive basic HIV care

A Johns Hopkins University School of Medicine study of insurance coverage of more than 28,000 people with HIV concludes that a decades-old program that offers free medical care remains a critical necessity despite the availability of coverage under the Affordable Care Act (ACA). [More]
RVFV uses cancer pathway to hijack host cell and cause infection

RVFV uses cancer pathway to hijack host cell and cause infection

Viruses can't live without us -- literally. As obligate parasites, viruses need a host cell to survive and grow. Scientists are exploiting this characteristic by developing therapeutics that close off pathways necessary for viral infection, essentially stopping pathogens in their tracks. [More]
Study links whole grain consumption to positive health effects

Study links whole grain consumption to positive health effects

Eating three more portions of dietary fiber a day--say, two pieces of whole grain bread and a bowl of whole grain breakfast cereal--is associated with a lower risk for all cardiovascular diseases and for dying of cancer, diabetes, and respiratory and infectious diseases, a study just published in the BMJ has shown. [More]
Blood pressure medications can lower stroke, heart attack risk in patients with end-stage renal disease

Blood pressure medications can lower stroke, heart attack risk in patients with end-stage renal disease

Two classes of blood pressure medications, angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs), are associated with a 16% lower risk of strokes, heart attacks and death in patients with end-stage renal disease who are undergoing peritoneal dialysis, a new study in the journal, Nephrology Dialysis Transplantation, reports. [More]
Emergence of multidrug-resistant salmonella strains increases burden of neglected diseases in Africa

Emergence of multidrug-resistant salmonella strains increases burden of neglected diseases in Africa

"The affected countries will have a major problem if we do not manage to control salmonella bloodstream infections with new antibiotics such as ciprofloxacin," cautions Prof Jürgen May. [More]
Topical delivery of AVR drug combination can provide complete protection against HIV

Topical delivery of AVR drug combination can provide complete protection against HIV

Researchers are edging ever closer to discovering the perfect combination of drugs and drug delivery system that will stop the sexual transmission of HIV. [More]
Adequate maternal folate may protect children from future obesity risk

Adequate maternal folate may protect children from future obesity risk

Proper maternal folate levels during pregnancy may protect children from a future risk of obesity, especially those born to obese mothers, according to a study led by researchers funded by the National Institutes of Health. [More]
T memory cells with naive phenotype can help boost immunity in older adults

T memory cells with naive phenotype can help boost immunity in older adults

Sixty-five is the age when many people retire, kick back and take it easy. And so it often is with the human immune system. [More]
Early-life peanut consumption feasible and nutritionally safe for children, study finds

Early-life peanut consumption feasible and nutritionally safe for children, study finds

Introducing peanut-containing foods during infancy as a peanut allergy prevention strategy does not compromise the duration of breastfeeding or affect children's growth and nutritional intakes, new findings show. [More]
New model helps predict outbreaks of zoonotic diseases

New model helps predict outbreaks of zoonotic diseases

A model that predicts outbreaks of zoonotic diseases -- those originating in livestock or wildlife such as Ebola and Zika -- based on changes in climate, population growth and land use has been developed by a UCL-led team of researchers. [More]
New vaccine found safe, effective against Toxic Shock Syndrome

New vaccine found safe, effective against Toxic Shock Syndrome

Toxic Shock Syndrome (TSS) is a severe circulatory and organ failure caused by bacterial toxins, usually triggered by bacteria from the Staphylococcus group. Researchers from MedUni Vienna's Department of Clinical Pharmacology, in collaboration with the company Biomedizinische Forschungsgesellschaft mbH in Vienna, have now developed the world's first safe and effective vaccine against this disease and successfully tested it in a Phase I trial. [More]
Advertisement